Table 1.
Basic demographic data, HIV staging, weight categorization and previous TB episodes recorded at the time of HAART initiation, comparing those treated for TB to those not treated for TB
| All children who received HAART | Treated for TB during study period | Not treated for TB during study period | p-value | |
| Total number | 290 (100%) | 140#‡ (100%) | 150## (100%) | |
| Gender | ||||
| Male | 143 (49%) | 67 (48%) | 76 (51%) | 0.43 |
| Age (months) | ||||
| Range/median | 1–160/23.5 | 2–140/19 | 1–160/33.5 | 0.08 |
| WHO HIV staging* | ||||
| CD4 depletion | ||||
| not significant | 22 (8%) | 4 (3%) | 18 (12%) | NA |
| mild | 26 (9%) | 9 (6%) | 17 (11%) | 0.14 |
| advanced | 31 (11%) | 10 (7%) | 21 (14%) | 0.06 |
| severe | 211 (73%) | 117 (84%) | 94 (63%) | <0.001 |
| Clinical stage | ||||
| II | 15 (5%) | 1 (1%) | 14 (9%) | NA |
| III | 128 (44%) | 50 (36%) | 78 (52%) | <0.01 |
| IV | 144 (50%) | 89 (63%) | 55 (37%) | <0.001 |
| Unknown | 3 (1%) | 0 (0%) | 3 (2%) | NA |
| Weight categories | ||||
| <60% EWA** | 43 (15%) | 29 (21%) | 14 (9%) | <0.01 |
| 60–80% EWA | 110 (38%) | 64 (46%) | 46 (31%) | <0.01 |
| 80–100% EWA | 92 (32%) | 34 (24%) | 58 (39%) | <0.01 |
| >100% EWA | 25 (9%) | 6 (4%) | 19 (13%) | 0.01 |
| Unknown | 20 (7%) | 7 (5%) | 13 (8%) | 0.22 |
| Previous TB | ||||
| 1 episode | 76 (26%) | 19 (14%) | 57 (38%) | <0.001 |
| ≥2 episodes | 12 (4%) | 7 (5%) | 5 (3%) | NA |
*WHO, World Health Organization immunological classification of HIV-associated immunodeficiency in infants and children, 2006
**EWA, expected weight for age
# Includes 4 children subsequently excluded due to incomplete data
## Includes 5 children with BCG disease only, who were excluded from further TB analysis
NA – not applicable, sample proportions too small for Z test